EA201200720A1 - Способ лечения системного слабо выраженного воспаления - Google Patents

Способ лечения системного слабо выраженного воспаления

Info

Publication number
EA201200720A1
EA201200720A1 EA201200720A EA201200720A EA201200720A1 EA 201200720 A1 EA201200720 A1 EA 201200720A1 EA 201200720 A EA201200720 A EA 201200720A EA 201200720 A EA201200720 A EA 201200720A EA 201200720 A1 EA201200720 A1 EA 201200720A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
inflammation
weakly expressed
system weakly
expressed
Prior art date
Application number
EA201200720A
Other languages
English (en)
Inventor
Йохан Рауд
Карл-Йохан Далсгаард
Original Assignee
Кардоз Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кардоз Аб filed Critical Кардоз Аб
Publication of EA201200720A1 publication Critical patent/EA201200720A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Предложено использовать пемироласт или его фармацевтически приемлемую соль для лечения системного слабо выраженного воспаления.
EA201200720A 2009-11-13 2010-11-12 Способ лечения системного слабо выраженного воспаления EA201200720A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26094909P 2009-11-13 2009-11-13
PCT/GB2010/002096 WO2011058331A1 (en) 2009-11-13 2010-11-12 Pemirolast for the treatment of systemic low grade inflammation

Publications (1)

Publication Number Publication Date
EA201200720A1 true EA201200720A1 (ru) 2013-02-28

Family

ID=43479356

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201200720A EA201200720A1 (ru) 2009-11-13 2010-11-12 Способ лечения системного слабо выраженного воспаления

Country Status (12)

Country Link
US (1) US20120329813A1 (ru)
EP (1) EP2498779A1 (ru)
JP (1) JP2013510837A (ru)
KR (1) KR20120115496A (ru)
CN (1) CN102724982A (ru)
AU (1) AU2010317712A1 (ru)
BR (1) BR112012011231A2 (ru)
CA (1) CA2780382A1 (ru)
EA (1) EA201200720A1 (ru)
IL (1) IL219710A0 (ru)
MX (1) MX2012005513A (ru)
WO (1) WO2011058331A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110092463A1 (en) * 2008-04-07 2011-04-21 Johan Raud Combination for use in the treatment of inflammatory disorders
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
KR102096204B1 (ko) * 2019-05-31 2020-04-02 최명석 국소지방 파괴 방법 및 국소지방 파괴용 저장성 용액

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8686189B2 (en) 2005-09-16 2014-04-01 Daiichi Sankyo Company, Limited Optically active diamine derivative and process for producing the same
ES2394984T3 (es) * 2006-12-18 2013-02-07 Cardoz Ab Nueva combinación para uso en el tratamiento de trastornos inflamatorios
AU2007336077A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
CA2693628A1 (en) * 2007-07-11 2009-01-15 Cardoz Ab New combination for use in the treatment of imflammatory disorders
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009122182A1 (en) * 2008-04-04 2009-10-08 Cardoz Ab New combination for use in the treatment of inflammatory disorders
US20110092463A1 (en) * 2008-04-07 2011-04-21 Johan Raud Combination for use in the treatment of inflammatory disorders
PT2443120T (pt) * 2009-06-16 2017-02-08 Rspr Pharma Ab Forma cristalina de pemirolast

Also Published As

Publication number Publication date
CN102724982A (zh) 2012-10-10
JP2013510837A (ja) 2013-03-28
CA2780382A1 (en) 2011-05-19
EP2498779A1 (en) 2012-09-19
AU2010317712A1 (en) 2012-05-24
WO2011058331A1 (en) 2011-05-19
US20120329813A1 (en) 2012-12-27
BR112012011231A2 (pt) 2016-04-05
IL219710A0 (en) 2012-07-31
MX2012005513A (es) 2012-06-19
KR20120115496A (ko) 2012-10-18

Similar Documents

Publication Publication Date Title
IL262956B (en) Methods for increasing efficacy of folr1 cancer therapy
EP2600836A4 (en) CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN
EP2488025A4 (en) SEPIAPTERIC INTREDUCTASE INHIBITION FOR PAIN TREATMENT
EA201500362A1 (ru) Ингибиторы rho-киназы
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
HUE059033T2 (hu) Benzoxaborol-származékok bakteriális fertõzések kezelésére
EP2726066A4 (en) DOSE FORMS FOR ORAL ADMINISTRATION AND TREATMENT METHODS THEREWITH
EP3030323A4 (en) Kdm1a inhibitors for the treatment of disease
EP2734500A4 (en) SELECTIVE HISTONDEACETYLASE-6 INHIBITORS FOR THE TREATMENT OF BONE DISORDERS
IL223201A (en) Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
PL2427193T3 (pl) Zastosowanie inhibitorów pde7 do leczenia zaburzeń ruchu
EP2552417A4 (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF BLADDER HYPERACTIVITY
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
MY162397A (en) Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
PH12012501389A1 (en) Hedgehog inhibitors
EA201290808A1 (ru) Замещенные конденсированные производные имидазола, фармацевтические композиции и способы их применения
IL225755A0 (en) Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain
EP2536436A4 (en) ANTIMIR-451 FOR THE TREATMENT OF POLYCYCLES
PL2790712T3 (pl) Podpopulacja ludzkich monocytów do leczenia uszkodzenia ośrodkowego układu nerwowego
EP2522360A4 (en) VACCINE FOR TAUTOPATHY TREATMENT
PL392436A1 (pl) Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
SMT201600479B (it) Nuove soluzioni terapeutiche per il trattamento di condizioni neuroinfiammatorie
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.